MedTrace Logo

Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone

NCT03704584 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2022-10-12

Study results available
· View outcomes & findings →

Summary

The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve entrapments that are often treated with a combination of these injectates.

Conditions

  • Tenosynovitis

Interventions

DRUG

Treatment Group: Corticosteroid injection

Subjects will receive a corticosteroid injection that is 40 mg/mL injection of Methylprednisolone or 40mg/mL injection of methylacetate injectable suspension or 40 mg/mL triamcinolone.

DRUG

Control Group (corticosteroid alone)

Control Group (corticosteroid alone) subjects will receive (40 mg/mL injection of Methylprednisolone acetate injectable suspension or 40 mg/mL triamcinolone) .

DRUG

Treatment Group: Lidocaine

Subjects will receive an injection of lidocaine (1% lidocaine HCl).

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Charles Daly, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-14
Primary Completion
2020-01-14
Completion
2020-01-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03704584 on ClinicalTrials.gov